Scarica l'app Stockscreener
17.91
3.19%
-0.59
Dopo l'orario di chiusura:
18.20
0.29
+1.62%
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views? - Yahoo Finance
Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
What's Driving the Market Sentiment Around ADMA Biologics? - Benzinga
Commit To Buy ADMA Biologics At $10, Earn 14% Using Options - Nasdaq
Bank of New York Mellon Corp Has $26.09 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Mutual of America Capital Management LLC Has $614,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook - MSN
Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Lisanti Capital Growth LLC Sells 59,565 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Mizuho lifts ADMA Biologics price target to $32, maintains Outperform - Investing.com
How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85% - MSN
ADMA Biologics Stock Climbs Amid Strong Earnings - TipRanks
ADMA Biologics (NASDAQ:ADMA) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Buy Rating Affirmed for ADMA Biologics Amid Transition to New Auditor and Growth Prospects - TipRanks
ADMA Biologics Earnings Call Highlights Strong Growth - TipRanks
ADMA Biologics Inc earnings beat by $0.31, revenue topped estimates - Investing.com Australia
BREAKING: Block & Leviton Investigating ADMA Biologics, - GlobeNewswire
BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed - EIN News
ADMA Biologics slips as 10-K delay overshadows earnings beat - MSN
ADMA Biologics stock slips on 10-K delay (ADMA:NASDAQ) - Seeking Alpha
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript - Insider Monkey
ADMA Biologics Reports Strong 2024 Financial Performance - MSN
ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Earnings call transcript: ADMA Biologics Q4 2024 beats EPS forecast - Investing.com India
ADMA Biologics Delays 10-K Filing Amid Auditor Change - TipRanks
Earnings call transcript: ADMA Biologics Q4 2024 beats EPS forecast By Investing.com - Investing.com Canada
ADMA Biologics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ADMA BIOLOGICS Earnings Results: $ADMA Reports Quarterly Earnings - Nasdaq
Adma Biologics sees FY26 revenue at least $605M - TipRanks
Adma Biologics: Q4 Earnings Snapshot - CTPost
ADMA Biologics Swings to Q4 Profit, Revenue Increases; Shares Rise After Hours -March 03, 2025 at 04:47 pm EST - Marketscreener.com
ADMA Biologics stock jumps over 4% on strong Q4 results, raised guidance - Investing.com
Adma Biologics: Q4 Earnings Snapshot -March 03, 2025 at 04:40 pm EST - Marketscreener.com
ADMA Biologics Reports Strong Financial Performance in 2024 - TradingView
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
ADMA Biologics Reports 65% Revenue Growth and Significant Increase in Net Income for FY 2024 - Nasdaq
Earnings Flash (ADMA) Adma Biologics Reports Q4 Revenue $117.5M, vs. FactSet Est of $112.8M - Marketscreener.com
Adma Biologics options imply 11.5% move in share price post-earnings - TipRanks
Earnings Scheduled For March 3, 2025 - Benzinga
New York State Common Retirement Fund Sells 11,550 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Shareholder Rights Advocates at Levi & Korsinsky Investigate ADMA Biologics, Inc. (ADMA) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Okta, Gitlab, ADMA Biologics set to report earnings Friday By Investing.com - Investing.com South Africa
Okta, Gitlab, ADMA Biologics set to report earnings Friday - Investing.com
ADMA Biologics Inc (ADMA) Q4 2024: Everything You Need To Know A - GuruFocus.com
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):